Multiple congenital exostoses
ICD-10 Q78.6 is a billable code used to indicate a diagnosis of multiple congenital exostoses.
Multiple congenital exostoses, also known as hereditary multiple exostoses (HME), is a genetic disorder characterized by the development of multiple benign bone tumors (exostoses) that typically arise from the growth plates of long bones. These exostoses can lead to deformities and functional impairments, particularly in the musculoskeletal system. Patients may present with limb deformities, joint pain, and restricted mobility due to the presence of these bony growths. The condition is often inherited in an autosomal dominant pattern, and while it primarily affects the long bones, exostoses can also occur in other areas such as the pelvis and spine. Clinical management may involve monitoring for complications, surgical intervention for symptomatic exostoses, and addressing associated musculoskeletal issues such as scoliosis or limb length discrepancies. Accurate coding is essential for appropriate treatment planning and resource allocation in pediatric patients.
Detailed growth and developmental assessments, imaging studies, and treatment plans must be documented to support the diagnosis.
Pediatric patients presenting with limb pain, deformities, or functional limitations due to multiple exostoses.
Consideration of growth patterns and potential for surgical intervention in growing children.
Genetic counseling notes, family history, and results of genetic testing should be included to support the diagnosis.
Patients undergoing genetic evaluation for hereditary multiple exostoses and family planning discussions.
Understanding the inheritance pattern and implications for family members is crucial.
Used when joint pain is present due to exostoses.
Document the reason for the procedure and the joint involved.
Pediatric considerations for sedation and pain management.
Treatment options may include monitoring for growth and symptoms, surgical removal of symptomatic exostoses, and physical therapy to improve mobility and function. Regular follow-up is essential to manage any complications.
